| 2023 | | A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea | 최윤석 |
| 2020 | | A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis | 서창희 |
| 2021 | | Activation of formyl peptide receptor 1 elicits therapeutic effects against collagen-induced arthritis | 양시영 |
| 2020 | | ADAM17 Genetic Variants and the Response of TNF-alpha Inhibitor in Rheumatoid Arthritis Patients | 김현아, 정주양 |
| 2023 | | Biosimilars in the treatment of rheumatoid arthritis: a pharmacokinetic overview | 서창희 |
| 2018 | | Clinical Results of Autogenous Palmaris Longus Tendon Graft for Ruptures of Multiple Extensors in Rheumatoid Hands | 최완선 |
| 2018 | | Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial | 서창희 |
| 2022 | | Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry | 김현아 |
| 2023 | | Effects of a self-determination theory-based physical activity programme for postmenopausal women with rheumatoid arthritis: A randomized controlled trial | 김춘자, 안정아 |
| 2019 | | Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial | 서창희 |
| 2018 | | Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months | 서창희 |
| 2021 | | Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Impact of concomitant methotrexate on disease activity in patients with rheumatoid arthritis tapering abatacept: results from KOBIO registry | 김현아 |
| 2018 | | Inhibition of Notch1 induces population and suppressive activity of regulatory T cell in inflammatory arthritis | 강이중, 양시영 |
| 2019 | | Injectable Click-Crosslinked Hyaluronic Acid Depot To Prolong Therapeutic Activity in Articular Joints Affected by Rheumatoid Arthritis | 민병현 |
| 2023 | | Predicting physical activity and sarcopenia-related health outcomes in women with rheumatoid arthritis: A test of the self-determination theory | 김춘자, 정주양 |
| 2018 | | Prevalence and Fracture Risk of Osteoporosis in Patients with Rheumatoid Arthritis: A Multicenter Comparative Study of the FRAX and WHO Criteria | 김현아, 서창희, 정주양 |
| 2019 | | Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study | 김현아 |
| 2024 | | Uncovering risk factors for adverse events and infections in rheumatoid arthritis and rheumatoid arthritis with interstitial lung disease under treatment with biologics or targeted synthetic DMARDs: insights from the KOBIO Registry | 김지원, 김현아, 서창희, 정주양 |
